Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Flavin-Conjugated Pt(IV) Anticancer Agents
Juan Sánchez-Camacho, Sonia Infante-Tadeo, Ana C. Carrasco, et al.
Inorganic Chemistry (2023) Vol. 62, Iss. 14, pp. 5644-5651
Open Access | Times Cited: 22

Showing 22 citing articles:

Nuclear-Targeting Lipid PtIV Prodrug Amphiphile Cooperates with siRNA for Enhanced Cancer Immunochemotherapy by Amplifying Pt-DNA Adducts and Reducing Phosphatidylserine Exposure
Dengshuai Wei, Junning Fan, Jianqin Yan, et al.
Journal of the American Chemical Society (2023) Vol. 146, Iss. 1, pp. 1185-1195
Closed Access | Times Cited: 39
Bithiophene‐Functionalized Infrared Two‐Photon Absorption Metal Complexes as Single‐Molecule Platforms for Synergistic Photodynamic, Photothermal, and Chemotherapy
Xue‐Lian Li, Mengfan Wang, Lizhen Zeng, et al.
Angewandte Chemie International Edition (2024) Vol. 63, Iss. 27
Closed Access | Times Cited: 10
Dinuclear Dicationic Iridium Complexes for Highly Synergistic Photodynamic and Photothermal Therapy to Chemoresistant Cancer
Lizhen Zeng, Xue‐Lian Li, Yu‐Ang Deng, et al.
Inorganic Chemistry (2025)
Closed Access | Times Cited: 1
Alendronate PtIV Prodrug Amphiphile for Enhanced Chemotherapy Targeting and Bone Destruction Inhibition in Osteosarcoma
Kaichuang Sun, Lu Yuan, Chen Shen, et al.
Advanced Healthcare Materials (2023) Vol. 13, Iss. 7
Closed Access | Times Cited: 17
Pt(iv) anticancer prodrugs bearing an oxaliplatin scaffold: what do we know about their bioactivity?
Alvaro Lopez-Sanchez, Hélène Bertrand
Inorganic Chemistry Frontiers (2024) Vol. 11, Iss. 6, pp. 1639-1667
Closed Access | Times Cited: 7
Pt(IV) Complexes in the Search for Novel Platinum Prodrugs with Promising Activity
Sainath Babaji Aher, J. Zhu, Pundlik Rambhau Bhagat, et al.
Topics in Current Chemistry (2024) Vol. 382, Iss. 1
Closed Access | Times Cited: 7
Ruthenium complexes bearing nile red chromophore and one of its derivative: Theoretical evaluation of PDT‐related properties
Pierraffaele Barretta, Stefano Scoditti, Daniele Belletto, et al.
Journal of Computational Chemistry (2024) Vol. 45, Iss. 23, pp. 2034-2041
Closed Access | Times Cited: 5
The current status in computational exploration of Pt(iv) prodrug activation by reduction
Fortuna Ponte, Stefano Scoditti, Gloria Mazzone, et al.
Physical Chemistry Chemical Physics (2023) Vol. 25, Iss. 23, pp. 15586-15599
Open Access | Times Cited: 11
Pt(IV)-PROTAC Complexes with Synergistic Antitumor Activity and Enhanced Membrane Permeability
Chang‐Jiu Li, Z. Q. Zou, Shan Xu, et al.
Journal of Medicinal Chemistry (2025)
Closed Access
Catalytic Glutathione Oxidation and Platinum(IV) Prodrug Activation via a Ruthenium-Flavin Catalyst
Juan Sánchez-Camacho, Ana C. Carrasco, German E. Pieslinger, et al.
Organometallics (2025)
Closed Access
Pt(IV) Complexes as Anticancer Drugs and Their Relationship with Oxidative Stress
Vlad Iova, R.C. Tincu, Ioana Scrobotă, et al.
Biomedicines (2025) Vol. 13, Iss. 4, pp. 981-981
Open Access
Alloxazine-Based Ligands And Their Ruthenium Complexes As NADH Oxidation Catalysts And G4 Binders
Maria Jesus Moran, Laura Marretta, Lander Gaztelumendi, et al.
(2024)
Open Access | Times Cited: 2
Computational Assessment of Novel Ruthenium Phenoxazine‐Based Complexes as Photosensitizers in Photodynamic Therapy
Pierraffaele Barretta, Fortuna Ponte, Stefano Scoditti, et al.
European Journal of Inorganic Chemistry (2024) Vol. 27, Iss. 32
Open Access | Times Cited: 2
Synthesis and anticancer mechanisms of four novel platinum(ii) 4′-substituted-2,2′:6′,2′′-terpyridine complexes
Chun-Jie Liang, Run-Chun Wu, Xiaoqiong Huang, et al.
Dalton Transactions (2023) Vol. 53, Iss. 5, pp. 2143-2152
Closed Access | Times Cited: 4
Red-Light Photocatalytic Activation Of Pt(IV) Anticancer Prodrugs Using Methylene Blue
Ana C. Carrasco, Greta Bajetto, Stefano Scoditti, et al.
(2024)
Open Access | Times Cited: 1
Alloxazine-Based Ligands and Their Ruthenium Complexes as NADH Oxidation Catalysts and G4 Binders
Maria Jesus Moran, Laura Marretta, Lander Gaztelumendi, et al.
Inorganic Chemistry (2024) Vol. 63, Iss. 35, pp. 16362-16373
Closed Access | Times Cited: 1
Red-Light Photocatalytic Activation Of Pt(IV) Anticancer Prodrugs Using Methylene Blue
Ana C. Carrasco, Greta Bajetto, Stefano Scoditti, et al.
(2024)
Open Access | Times Cited: 1
Highly photoactive Ir(iii)–Pt(iv) heterometallic conjugates for anticancer therapy
Wangman Hu, Rongzhi Liu, Kai Zheng, et al.
Chemical Communications (2023) Vol. 60, Iss. 4, pp. 388-391
Closed Access | Times Cited: 3
Bithiophene‐Functionalized Infrared Two‐Photon Absorption Metal Complexes as Single‐Molecule Platforms for Synergistic Photodynamic, Photothermal, and Chemotherapy
Xue‐Lian Li, Mengfan Wang, Lizhen Zeng, et al.
Angewandte Chemie (2024) Vol. 136, Iss. 27
Closed Access
Pt(IV) Prodrug Photoactivation: A Promising Strategy for Cancer Therapy
Lingkai Tang, Yafei Luo, Wenqin Luo, et al.
Current Protein and Peptide Science (2024) Vol. 25, Iss. 10, pp. 797-813
Closed Access
Exploring the effect of the axial ligands on the anticancer activity of [C,N,N′] Pt(iv) cyclometallated compounds
Ariadna Lázaro, Ramón Bosque, Silvia Marín, et al.
Dalton Transactions (2024) Vol. 53, Iss. 31, pp. 13030-13043
Closed Access
Red‐Light Photocatalytic Activation Of Pt(IV) Anticancer Prodrugs Using Methylene Blue
Ana C. Carrasco, Greta Bajetto, Stefano Scoditti, et al.
ChemCatChem (2024)
Closed Access
Page 1

Scroll to top